About NORVELZO
NORVELZO is a Healthcare company based in Mumbai (India) founded in 2014. It serves as a distributor of generic pharmaceutical drugs to healthcare providers. It operates on a B2B model. Its website norvelzo.com draws about 681 thousand monthly visits. Its Indian entity Taj Pharmaceuticals Limited reported revenue of ₹6.31 Cr. Its focus areas include Pharmaceuticals, Distribution and Generic Drugs. Similar companies include Entero Healthcare, Keimed and Sandor Medicaids; 3 of its 3 listed similar companies have raised funding.
Company details
NORVELZO serves as a distributor of generic pharmaceutical drugs to healthcare providers through providing healthcare solutions, producing pharmaceutical products, distribution, and generic drugs. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Mumbai, India
- SectorsHealthcare
- Website norvelzo.com
- Legal Name Taj Pharmaceuticals Limited
- Date of Incorporation 05 Nov, 2004
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹6.31 Cr
FY 2024 · +31% YoY
- Net Profit₹10.7 Lakh
FY 2024 · 2% margin
- EBITDA₹1.30 Cr
FY 2024 · 21% margin
Associated legal entities of NORVELZO
NORVELZO operates through Taj Pharmaceuticals Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Taj Pharmaceuticals Limited CIN U24230MH2004PLC149424 | Active | 05 Nov 2004 | Mumbai, Maharashtra | ₹6.3 Cr | 3 | View details |
Board of directors of Taj Pharmaceuticals Limited (NORVELZO)
Taj Pharmaceuticals Limited is the primary company behind NORVELZO. The board of Taj Pharmaceuticals Limited currently have 3 directors; the longest-serving is Ranvir Kumar Bindeshwari Singh, appointed in 2004. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ranvir Kumar Bindeshwari Singh DIN 01725251 | Director | 05 Nov 2004 | 21 yrs 11 mo | Taj Pharmaceuticals Limited |
| Abhishek Ranvir Singh DIN 02706332 | Director | 10 Mar 2009 | 17 yrs 7 mo | Taj Pharmaceuticals Limited |
| Sudheer Singh DIN 06795666 | Director | 21 May 2013 | 13 yrs 5 mo | Taj Pharmaceuticals Limited |
Financials of NORVELZO
Figures of Taj Pharmaceuticals Limited, the primary company behind NORVELZO, for FY 2024. Revenue was ₹6.31 Cr (+31% year on year). Net profit was ₹10.7 Lakh (2% margin). EBITDA was ₹1.30 Cr (21% margin). Revenue has grown at a compounded annual rate of +23% over three years and +3% over five years.
- ₹6.31 CrRevenue · FY 2024 · +31% YoY
- ₹10.7 LakhNet profit · 2% margin
- ₹1.30 CrEBITDA · 21% margin
- ₹1.05 CrPaid-up capital
- +23%Revenue CAGR, 3 years
- +3%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Taj Pharmaceuticals Limited are on its company page.
Detailed financial statements for NORVELZO
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to NORVELZO
NORVELZO has 3 listed similar companies in our database, 3 of them funded. They include Entero Healthcare, Keimed and Sandor Medicaids.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| enterohealthcare.com | 2018 | Mumbai, India | $59.67M | 817 | India's leading healthcare products distribution platform | |
| keimed.com | 2000 | Hyderabad, India | $16.62M | 588 | Temperature-sensitive medicines are distributed via cold chain logistics by Keimed. | |
| sandor.co.in | 1995 | Hyderabad, India | $8.98M | 161 | Provider of medical equipment, devices, and drugs distribution services |
Detailed similar companies of NORVELZO
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of NORVELZO
The website of NORVELZO (norvelzo.com) receives about 680.7K visits a month.
- Monthly visits680.7K
▼ 6.7% vs previous month
Websites whose visitors overlap most with NORVELZO. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| falconebiz.com | 100% | 959.8K | #63,970 | View details | |
| tofler.in | 97% | 556K | #105,509 | View details | |
| zaubacorp.com | 96% | 4.9M | #12,689 | View details | |
| tracxn.com | 92% | 2.9M | #16,597 | View details | |
| indiafilings.com | 90% | 2.1M | #29,959 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for NORVELZO
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Norvelzo
Complete news archive for NORVELZO
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NORVELZO
NORVELZO was founded in 2014.
NORVELZO is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
The primary company behind NORVELZO, Taj Pharmaceuticals Limited, reported revenue of ₹6.31 Cr for FY 2024, up 31% year on year.
NORVELZO serves as a distributor of generic pharmaceutical drugs to healthcare providers through providing healthcare solutions, producing pharmaceutical products, distribution, and generic drugs. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
NORVELZO's top competitors include Entero Healthcare, Keimed and Sandor Medicaids.
NORVELZO operates through Taj Pharmaceuticals Limited.
The legal entities of NORVELZO currently have 3 directors, including Ranvir Kumar Bindeshwari Singh, Abhishek Ranvir Singh, Sudheer Singh.
The website of NORVELZO receives about 681 thousand visits a month.